Main Session: Advances in Extended Adjuvant HER2-Positive Early Breast Cancer

How do I select patients for treatment with extended adjuvant therapies such as neratinib?

G. Thomas Budd, MD

G. Thomas Budd, MD, on advances in extended adjuvant HER2+ early breast cancer.


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here